Tavakoli, Manouche; Prach, Andrzej T.; Malek, Mo; … - In: PharmacoEconomics 16 (1999) 4, pp. 355-365
Background: Much has been published on the efficacy and cost effectiveness of Helicobacter pylori eradication treatment as an alternative to histamine H2-receptor antagonist maintenance treatment in peptic ulcer disease. However, most studies have analysed and emphasised H. pylori eradication...